petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.
Company profile
Ticker
PETS
Exchange
Website
CEO
Menderes Akdag
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Southeastern Veterinary Exports, Inc. • Global Veterinary Supply, Inc. • 420 South Congress Avenue, LLC • Harry Merger Sub, Inc. • PetMeds Insurance Services, LLC • Congress Park South Owners Association, Inc. • A not-for-profit corporation; 420 South Congress Avenue, LLC ...
IRS number
650680967
PETS stock data
Latest filings (excl ownership)
8-K
Results of Operations and Financial Condition
15 Apr 24
10-Q
2024 Q3
Quarterly report
15 Apr 24
10-K/A
2023 FY
Annual report (amended)
15 Apr 24
8-K
PetMeds® Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
15 Feb 24
NT 10-Q
Notice of late quarterly filing
9 Feb 24
8-K
PetMeds® Announces Selected Preliminary Third Quarter Financial Results
8 Feb 24
8-K
Other Events
8 Jan 24
10-Q
2024 Q2
Quarterly report
31 Oct 23
Transcripts
PETS
Earnings call transcript
2024 Q3
8 Feb 24
PETS
Earnings call transcript
2024 Q2
30 Oct 23
PETS
Earnings call transcript
2024 Q1
1 Aug 23
PETS
Earnings call transcript
2023 Q4
22 May 23
PETS
Earnings call transcript
2023 Q3
6 Feb 23
PETS
Earnings call transcript
2022 Q2
8 Nov 22
PETS
Earnings call transcript
2022 Q1
26 Jul 22
PETS
Earnings call transcript
2021 Q4
10 May 22
PETS
Earnings call transcript
2022 Q3
6 Feb 22
PETS
Earnings call transcript
2021 Q3
25 Jan 22
Latest ownership filings
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G
RENAISSANCE TECHNOLOGIES LLC
13 Feb 24
SC 13G/A
BlackRock Inc.
25 Jan 24
4
Mark Bradley Moseley JR
12 Dec 23
4
GIAN FULGONI
13 Nov 23
4
Mathew N Hulett
7 Nov 23
4
Christine Chambers
7 Nov 23
4
Jacqueline Paula Smith
16 Aug 23
4
Jacqueline Paula Smith
16 Aug 23
4
Leslie C.G. Campbell
4 Aug 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Mar 22 | Mar 21 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 53.47 mm | 53.47 mm | 53.47 mm | 53.47 mm | 53.47 mm | 53.47 mm |
Cash burn (monthly) | 2.69 mm | 3.59 mm | 147.00 k | 870.83 k | 259.00 k | (no burn) |
Cash used (since last report) | 18.38 mm | 24.54 mm | 1.01 mm | 5.95 mm | 1.77 mm | n/a |
Cash remaining | 35.09 mm | 28.93 mm | 52.47 mm | 47.52 mm | 51.70 mm | n/a |
Runway (months of cash) | 13.1 | 8.1 | 356.9 | 54.6 | 199.6 | n/a |
Institutional ownership, Q3 2023
61.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 141 |
Opened positions | 23 |
Closed positions | 33 |
Increased positions | 38 |
Reduced positions | 50 |
13F shares | Current |
---|---|
Total value | 130.95 bn |
Total shares | 12.97 mm |
Total puts | 437.00 k |
Total calls | 335.50 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 1.75 mm | $17.96 bn |
Vanguard | 1.18 mm | $12.12 bn |
Renaissance Technologies | 1.14 mm | $11.73 bn |
Mirae Asset Global Investments | 737.55 k | $7.56 bn |
Dimensional Fund Advisors | 690.47 k | $7.08 bn |
Citadel Advisors | 500.79 k | $5.13 bn |
STT State Street | 489.97 k | $5.02 bn |
Hotchkis & Wiley Capital Management | 480.89 k | $4.93 bn |
Geode Capital Management | 447.90 k | $4.59 bn |
Oaktop Capital Management Ii | 435.84 k | $4.47 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Dec 23 | Mark Bradley Moseley JR | Common Stock | Grant | Acquire A | No | No | 7.14 | 14,000 | 99.96 k | 42,000 |
9 Nov 23 | Gian Fulgoni | Common Stock | Buy | Acquire P | No | No | 7.3445 | 41,000 | 301.12 k | 109,510 |
3 Nov 23 | Christine Chambers | Common Stock | Buy | Acquire P | No | No | 7.26 | 6,888 | 50.01 k | 19,888 |
3 Nov 23 | Mathew N Hulett | Common Stock | Buy | Acquire P | No | No | 7.26 | 13,850 | 100.55 k | 613,850 |
14 Aug 23 | Jacqueline Paula Smith | RSU | Grant | Acquire A | No | No | 0 | 6,000 | 0.00 | 6,000 |
News
PetMed Express Q3 2024 EPS $(0.10) Misses $(0.01) Estimate, Sales $65.317M Beat $65.000M Estimate
15 Apr 24
PetMed Express Q3 2024 GAAP EPS $(0.10), Sales $65.317M Beat $65.000M Estimate
15 Apr 24
11 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
6 Mar 24
PetMeds® Announces Selected Preliminary Q3 Financial Results; Sees Q3 Revenue $65.3M Vs 68M Est.
8 Feb 24
Earnings Scheduled For February 8, 2024
8 Feb 24
Press releases
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
15 Apr 24
PetMeds® to Give Away Free Pet Food for a Year to Three Lucky Pet Owners and $1,000 in PetMeds® Credits to Three Local Animal Shelters
16 Feb 24
PetMeds® Announces Selected Preliminary Third Quarter Financial Results
8 Feb 24